DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Stem Cell Transplantation for the Treatment of Knee Osteoarthritis

Information source: Tehran University of Medical Sciences
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Knee Osteoarthritis

Intervention: Autologous Stem Cell Transplantation (Biological)

Phase: Phase 1

Status: Recruiting

Sponsored by: Tehran University of Medical Sciences

Official(s) and/or principal investigator(s):
Fereydoun Davatchi, MD, Study Chair, Affiliation: Rheumatology Research Center, Medical Sciences/University of Teheran
Behrouz Nikbin, MD, Principal Investigator, Affiliation: Department of Immunology, Medical Sciences/University of Tehran

Overall contact:
Fereydoun Davatchi, MD, Phone: (98-21) 8802-6956, Email: fddh@davatchi.net

Summary

The purpose of this study is to find if autologous stem cell transplantation can improve clinical manifestations of knee osteoarthritis.

Clinical Details

Official title: Phase 1 Study of Bone Marrow - Derived Stem Cell for the Treatment of Knee Osteoarthritis

Study design: Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study

Primary outcome: 1- Comparison of pain in the injected knee with the controlateral knee 2- Comparison of joint motion of the injected knee with the controlateral knee

Secondary outcome: Evaluation of side-effects

Eligibility

Minimum age: 40 Years. Maximum age: 70 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Moderate bilateral knee osteoarthritis

Exclusion Criteria:

- No infectious or inflammatory arthritis

Locations and Contacts

Fereydoun Davatchi, MD, Phone: (98-21) 8802-6956, Email: fddh@davatchi.net

Rheumatology Research Center, Behcet's Disease Unit (Shariati Hospital), Tehran 14114, Iran, Islamic Republic of; Recruiting
Fereydoun Davatchi, MD, Phone: (98-21)8802-6956, Email: fddh@davatchi.net
Fereydoun Davatchi, MD, Principal Investigator
Bahar Sadeghi-Abdollahi, MD, Sub-Investigator
Masoomeh Akhlaghi, MD, Sub-Investigator
Tahereh Faezi, MD, Sub-Investigator
Additional Information

Related publications:

Le Blanc K. [Mesenchymal stem cells. Basic science and future clinical use] Lakartidningen. 2002 Mar 21;99(12):1318-21, 1324. Review. Swedish.

Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991 Sep;9(5):641-50.

Caplan AI, Elyaderani M, Mochizuki Y, Wakitani S, Goldberg VM. Principles of cartilage repair and regeneration. Clin Orthop Relat Res. 1997 Sep;(342):254-69.

Solchaga LA, Welter JF, Lennon DP, Caplan AI. Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. Methods Mol Med. 2004;100:53-68.

Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007 Nov;213(2):341-7.

Starting date: December 2007
Ending date: June 2010
Last updated: February 7, 2009

Page last updated: February 12, 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012